Mount Sinai Study Identifies New Gene Variations Associated With Heart Rate
April 14, 2013
Findings pinpoint 14 genetic targets in humans that may provide insight for the treatment of cardiovascular disease
Personalized Medicine Takes A Giant Step Forward At The Mount Sinai Medical Center
April 5, 2013
New ‘CLIPMERGE’ program helps physicians identify gene-drug interactions to improve treatment decisions.
Mount Sinai Receives $3.4 Million Grant to Initiate First-Of-Its-Kind Study of Personalized Medicine in the Clinical Setting
August 18, 2011
Dr. Erwin Bottinger and his team are initiating the largest study to date using genetic information to help tailor individualized treatments in heart disease patients.
Data From Mount Sinai Biobank Provides Critical Insight Into Personalized Medicine
May 4, 2011
Mount Sinai researchers find that population labels may not be helpful in predicting disease risk or guiding how a patient will respond to certain medications, as previously thought.
Mount Sinai Charles R. Bronfman Institute for Personalized Medicine Biobank Enrolls 14,000
February 5, 2011
The Mount Sinai IPM Biobank, a unique institution that serves Mount Sinai’s many genomic research projects, has enrolled 14,000 Mount Sinai patients.
Personalized Medicine Arrives At Mount Sinai Medical Center
October 15, 2010
Clinical demonstration project offers genetic testing to help doctors predict if their patient will benefit from antiplatelet drug clopidrogel